Plasma mediated treatment along with Interferon β mechanism for symptomatic Covid 19/20 treatment and generation of asymptomatic conditions for Covid 19/20 with contrast to IBV Avian virus.
European Journal of Molecular & Clinical Medicine,
2021, Volume 8, Issue 3, Pages 45-54
Abstract
Covid 19 virus has shown its terror by causing severe acute respiratory disorder of human being’s effects shows a type of viral pneumonia. To address the anomaly the paper caries the motive encountering the viral infection with the help of interferon type 1 β. A basic discussion of effective INFβ1 and its introduction in the effective cells by Corona virus, plasma mediated delivery system along with development of asymptomatic conditions in non-affected individual. The plasma therapy considers plasma transfusion into effected individuals to boost their immunity against Corona virus. The plasma consists of antibodies, antigens as well as interferon to mediate with the viral infection and providing high effective rate. Satisfying these 2 goals was the basic motto of the paper along with a generation of asymptomatic condition in effected individuals. IBV (infectious bronchitis virus) is a type of influenza virus which has structural, genomic as well as symptomatic similarities with corona virus. Vaccination of non-effected individuals with IBV vac may allow to address the symptomatic similarities of Corona virus such as fever and breathing troubles. The generation of active immunity may render the extent of symptoms allowing persons to remain asymptomatic against the Corona infection. The study of structural phylogenomic of IBV along with Corona virus, and a contrast of similarities to support the asymptomatic postulates of the infected individuals has been explained.
Keywords:
- Article View: 633
- PDF Download: 463